K Number
K181455
Date Cleared
2018-09-10

(98 days)

Product Code
Regulation Number
878.4635
Reference & Predicate Devices
Predicate For
N/A
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

Tanning Bed Systems are intended to provide tanning of the human skin.

Device Description

The primary technical components of sunlamp products are whole body tanning devices consisting of a mechanical frame with Ultraviolet (UV) lamps providing an artificial source of UV radiation. The UV light is intended for irradiation of the human body to induce skin tanning. The user of the proposed devices device either lies in the horizontal tanning bed or stands in the vertical tanning booth.

Skin tanning varies with skin type and as the UV sources intensities with characteristic UV-A and UV-B proportions result in cosmetic tanning of the human skin.

The UV-A proportion primarily generates a superficial tan, which appears rapidly and is intensive but fades more rapidly. The UV-B radiation is primarily responsible for more longterm tanning results.

AI/ML Overview

This document describes ProSun International LLC's submission for their sunlamp products, establishing substantial equivalence to previously marketed predicate devices. This is a 510(k) submission for tanning bed systems, which are classified as Class II medical devices. The document does not describe an AI/ML powered device, therefore the typical acceptance criteria and study data for AI/ML devices involving human readers, test sets, ground truth, and training sets are not applicable.

Instead, the acceptance criteria for these devices revolve around compliance with established performance standards and safety regulations for sunlamp products.

Here's a breakdown of the requested information, adapted to the context of this device:


1. A table of acceptance criteria and the reported device performance

Acceptance Criteria (FDA Performance Standards & Guidance)Reported Device Performance (Summary of Performed Tests)
Biocompatibility: In accordance with DIN EN ISO 10993Non-clinically tested in accordance with DIN EN ISO 10993.
Electrical and Mechanical Safety: In accordance with IEC 60601-1 (IEC 60335-2-27 and UL 482)Non-clinically tested in accordance with IEC 60601-1 (IEC 60335-2-27 and UL 482).
EMC (Electromagnetic Compatibility): In accordance with IEC 60601-1-2 (CISPR 14-1 and 14-2)Non-clinically tested in accordance with IEC 60601-1-2 (CISPR 14-1 and 14-2).
Spectral Emissions: Measured in accordance with IEC 6033-2-27 and 21 CFR 1002, 1010-1050Spectral emissions of all sunlamp products were measured (test procedure in accordance with IEC 6033-2-27 and 21 CFR 1002, 1010-1050).
Irradiance Ratio Limits: In accordance with 21 CFR 1040.2(c)(1)Irradiance ratio limits of all proposed sunlamp products are in accordance with 21 CFR 1040.2(c)(1).
Software Verification & Validation: According to FDA's "Guidance for the Content of Premarket Submission for Software Contained in Medical Devices" (if applicable)Non-clinically tested for software verification & validation testing according to FDA's "Guidance for the Content of Premarket Submission for Software Contained in Medical Devices" (implying compliance, as the devices are presented as being substantially equivalent).
Maximum Timer Intervals and Exposure Schedules: Determined according to FDA's "Policy on maximum timer interval and exposure schedule for sunlamp products."The maximum timer intervals and exposure schedules have been determined according to FDA's "Policy on maximum timer interval and exposure schedule for sunlamp products." (The table in section 1.5.6 on page 6 details the "Max Exposure Min." for each model, ranging from 9 to 20 minutes, which represents the device's adherence to these schedules).
Performance Standards Testing: In accordance with 21 CFR 1040.20Performance Standards testing in accordance with 21 CFR 1040.20.

2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

This information is not applicable as this is not an AI/ML study involving a test set of data. The devices themselves are the "test set" and their performance is evaluated against regulatory standards. The testing described is primarily non-clinical, evaluating the physical device characteristics and compliance with electrical, mechanical, and radiation emission standards.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)

This information is not applicable. The "ground truth" for sunlamp products relies on established engineering and medical device safety standards and regulations (e.g., IEC, UL, 21 CFR). Expert review would be conducted by regulatory bodies and internal engineering teams to ensure compliance, rather than clinical experts establishing a ground truth for a diagnostic AI.

4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

This information is not applicable. This is not a study requiring adjudication of interpretations from multiple readers.

5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

This information is not applicable. This submission is for sunlamp products, not a device with AI assistance for human readers.

6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

This information is not applicable. These are physical sunlamp devices, not software algorithms.

7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)

The "ground truth" in this context is the set of established safety and performance standards, regulations, and internationally recognized testing procedures for sunlamp products. This includes:

  • 21 CFR 878.4635 (Regulation for Ultraviolet Lamp for Tanning)
  • 21 CFR 1040.20 (Performance standards for sunlamp products)
  • 21 CFR 1002, 1010-1050 (Electronic product radiation control)
  • IEC 60601-1 (Medical electrical equipment - General requirements for basic safety and essential performance)
  • IEC 60335-2-27 (Household and similar electrical appliances - Safety - Part 2-27: Particular requirements for appliances for skin exposure to ultraviolet and infrared radiation)
  • UL 482 (Standard for Portable Sun/Health Lamps)
  • DIN EN ISO 10993 (Biological evaluation of medical devices)
  • CISPR 14-1 and 14-2 (Electromagnetic compatibility for household appliances, electric tools and similar apparatus)
  • FDA Guidance documents (e.g., "Guidance for the Content of Premarket Submission for Software Contained in Medical Devices" and "Policy on maximum timer interval and exposure schedule for sunlamp products")

8. The sample size for the training set

This information is not applicable. This is not an AI/ML device that requires a training set.

9. How the ground truth for the training set was established

This information is not applicable. There is no training set for this device.

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.

September 10, 2018

ProSun International LLC Jennifer Henkemans COO- Chief Operating Officer 2442 23rd Street North Saint Petersburg, Florida 33713

Re: K181455

Trade/Device Name: ProSun sunlamp products, Luxura sunlamp products Regulation Number: 21 CFR 878.4635 Regulation Name: Ultraviolet Lamp For Tanning Regulatory Class: Class II Product Code: LEJ Dated: May 31, 2018 Received: June 4, 2018

Dear Jennifer Henkemans:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/ofdocs/ofpmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part

{1}------------------------------------------------

801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/CombinationProducts/GuidanceRegulatoryInformation/ucm597488.html; good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803). please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm.

For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely, Jennifer R. Stevenson -S3 For Binita S. Ashar, M.D., M.B.A., F.A.C.S. Director Division of Surgical Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

Indications for Use

Form Approved: OMB No. 0910-0120 Expiration Date: 06/30/2020 See PRA Statement below.

510(k) Number (if known)

Device Name

Lumina, Prosun, Luxura, Onyx, Jade, Sundream

Indications for Use (Describe)

Tanning Bed Systems are intended to provide tanning of the human skin.

Type of Use (Select one or both, as applicable)

| Prescription Use (Part 21 CFR 801 Subpart D)

Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

1.5 — 510(k) Summary

NON-CONFIDENTIAL SUMMARY OF SAFETY and EFFECTIVENESS In accordance with the requirements of the Safe Medical Device Act, FDA 21 CFR 807.92(c), ProSun International, LLC herein submits this Summary of Safety and Effectiveness for the Lumina, Prosun, Luxura, Onyx, and Jade sunlamp tanning bed product lines.

Submitter Information:

ProSun International LLC 2442 23rd Street North Saint Petersburg, Florida 33713-4018 Tel - 727-825-0400 Fax - 727-825-0700

Official Contact:

Jennifer C. Henkemans, Chief Operating Officer 2442 23rd Street North Saint Petersburg, Florida 33713-4018 Tel - 727-825-0400 Fax – 727-825-0700 jenniferh@prosun.com

Regulatory Consultant: N/A

Date Prepared: May 31, 2018

1.5.1 - PROPOSED DEVICE IDENTIFICATION

All proposed devices have originally been listed as Class I devices (510(k) exempt sunlamp product) and legally offered for sale before September 2, 2014. In accordance with the final order (Federal Register, Volume 79, Number 5) these proposed devices are used as predicate devices for substantial equivalence purposes.

Device Trade Name: ProSun sunlamp products Common Name: Prosun sunlamp products Classification Name: Booth, Sun Tan (21 CFR 878.4635, Product Code LEI) Classification Panel: General & Plastic Surgery Device Class: Class II

{4}------------------------------------------------

The following table presents the proposed ProSun sunlamp products. The Jade, Onyx, RelaxSun and ProSun sunlamp products represent technically and fundamentally the same basic products which do not alter any technical specifications or aspects of the devices.

Current ModelHistorical ModelMarketing NameBrand and Type Name
1224 Series12 VProSun Canopy Tanner
2424 SeriesRelaxSun 24RelaxSun 24
24J24 SeriesJADE 24ProSun Jade 24
2828 SeriesONYX 28ProSun ONYX 28
32J32 SeriesJADE 32ProSun Jade 32
3232 SeriesONYX 32ProSun ONYX 32
32/132 SeriesONYX 32 SLiProSun ONYX 32 SLi Intensive (110)
32/1-P32 SeriesONYX 32 SLiProSun ONYX 32 SLi Intensive (160)
36V36 Series VV1ProSun V1
42V342 Series VV3ProSun V3 42 XLc High Intensive
Device Trade Name:Luxura sunlamp products
Common Name:Luxura sunlamp products
Classification Name:Booth, Sun Tan (21 CFR 878.4635, Product Code LEJ)
Classification Panel:General & Plastic Surgery
Device Class:Class II

The following table presents the Luxura sunlamp products. The Luxura sunlamp products represent technically and fundamentally the same basic products which do not alter any technical specifications or aspects of the devices.

Current ModelHistorical ModelMarketing NameBrand and Type Name
34X34 SeriesX5Luxura 34 SLi Intensive
36X36 SeriesX3 (120)Luxura 36 SLi High Intensive
36X-P36 SeriesX3 (180)Luxura 36 SLi High Intensive
38X38 SeriesX5Luxura 38 SLi High Intensive
42X42 SeriesX7Luxura 42 SLi High Intensive
42V642 Series VV6Luxura 42 XL Ultra Intensive
48V648 Series VV6Luxura 48 XL Ultra Intensive
48V848 Series VV8Luxura 48 XL Ultra Intensive
48V8-E48 Series VV8 ELuxura V8 48 E-Power
52X/VEGAZ52 SeriesX10/VEGAZLuxura X10/VEGAZ

{5}------------------------------------------------

1.5.2 - DEVICE CLASSIFICATION

Classification Name: Booth, Sun Tan (21 CFR 878.4635, Product Code LEI) Classification Panel: General & Plastic Surgery Device Class: Class II

1.5.3 - DEVICE DESCRIPTION

The primary technical components of sunlamp products are whole body tanning devices consisting of a mechanical frame with Ultraviolet (UV) lamps providing an artificial source of UV radiation. The UV light is intended for irradiation of the human body to induce skin tanning. The user of the proposed devices device either lies in the horizontal tanning bed or stands in the vertical tanning booth.

Skin tanning varies with skin type and as the UV sources intensities with characteristic UV-A and UV-B proportions result in cosmetic tanning of the human skin.

The UV-A proportion primarily generates a superficial tan, which appears rapidly and is intensive but fades more rapidly. The UV-B radiation is primarily responsible for more longterm tanning results.

1.5.4 - INTENDED USE

Tanning Bed Systems are intended to provide tanning of the human skin.

1.5.5 - PREDICATE & SUBSTANTIAL EQUIVALENCE DEVICES

All proposed devices have originally been listed as Class I devices (510(k) exempt sunlamp product) and legally offered for sale before September 2, 2014. In accordance with the final order (Federal Register, Volume 79, Number 5) these proposed devices are used as predicate devices for substantial equivalence purposes.

1.5.6 - COMPARISON TO PREDICATE & SUBSTANTIAL EQUIVALENCE DEVICES

The following table represents the technological characteristics and parameters of the proposed devices.

{6}------------------------------------------------

ProSun International, LLC 2442 23rd Street North Saint Petersburg, Florida 33713-4018

NewModelNumberLegacyModelNumberMarketingNameBrand and TypeNameCanopyLampsLampWattsBenchLampsLampWattsFacialLampsLampWattsMaxExposureMin.
1224 Series12VCanopy Tanner12100n/a0n/a020
24J20
24 SeriesJADE 24Jade 241210012100n/a0
24RelaxSun20
24 Series24RelaxSun 241210012100n/a0
2828 SeriesONYX 28Onyx 281411014100n/a020
32/1-POnyx 32 Sli12
32 SeriesONYX 32 SliIntensive12160141001400
5140
32/132 SeriesONYX 32 SliOnyx 32 Sli1211014100140015
580
3232 SeriesONYX 32Onyx 321811014100n/a020
36V36 Series12
VV1Prosun V136110n/a0n/a0
36X-PLuxura 36 Sli HighIntensive12
36 SeriesX320160161803400
36XLuxura X3 36 SliIntensive15
36 SeriesX320160161203400
38XLuxura 38 Sli HighIntensive12
38 SeriesX522160161803400
42XLuxura 42 Sli HighIntensive12
42 SeriesX724160181804400
42V342 SeriesProsun V3 42 XLcHigh Intensive10
VV342160n/a0n/a0
42V642 SeriesLuxura 42 XLUltra Intensive10
VV642180n/a0n/a0
48V648 SeriesLuxura 48 V6 XLUltra Intensive9
VV648200n/a0n/a0
48V8-E48 SeriesLuxura V8 48 E-Power9
VV8-E48200n/a0n/a0
48V848 SeriesLuxura 48 XLUltra Intensive9
VV848200n/a0n/a0
52XLuxura 52 Sli HighIntensive10
52 SeriesX10/VEGAZ30160221804520

1.5.6 – COMPARISON TO PREDICATE & SUBSTANTIAL EQUIVALENCE DEVICES

The previous and following table represents the technological characteristics and parameters of the identified predicate devices and proposed devices. The Proposed Devices and the Predicate

{7}------------------------------------------------

Devices are the same devices which are unchanged and are totally equal. Therefore the list of Proposed Devices equals the Predicate Devices which are listed as follows.

NewModelNumberModelNumberMarketingNameBrand and TypeNameSubstantiallyEquivalentModelFDA 3630Accession #Old FDA3630Accession #FDA510(k)K#
1224 Series12VCanopy TannerProsun 12 /24 Series9520183-0089212092-00K944015
24J24 SeriesJADE 24Jade 24Prosun 24 Series9520183-0089520183-04K944015
2424 SeriesRelaxSun 24RelaxSun 24Prosun 24 Series9520183-0089520183-04K944015
2828 SeriesΟΝΥΧ 28Onyx 28Prosun 28 Series9520183-0099712092-02K944015
32/1-P32 SeriesΟΝΥΧ 32SliOnyx 32 SliIntensiveProsun 32 Series9520183-0099712092-02K944015
32/132 SeriesΟΝΥΧ 32SliOnyx 32 SliProsun 32 Series9520183-0099712092-02K944015
3232 SerirsΟΝΥΧ 32Onyx 32Prosun 32 Series9520183-0099712092-02K944015
36V36 SeriesV1Prosun V1Prosun 36 Series9922525-0019922527-00K944015
36X-P36 SeriesX3Luxura 36 SliHigh IntensiveProsun 36 Series9922525-0019922527-00K944015
36X36 SeriesX3Luxura X3 36 SliIntensiveProsun 36 Series9922525-0019922527-00K944015
38X38 SeriesX5Luxura 38 SliHigh IntensiveProsun 38 Series972092-008972092-06K944015
42X42 SeriesX7Luxura 42 SliHigh IntensiveProsun 42 Series972092-008972092-06K944015
42V342 SeriesV3Prosun V3 42 XLcHigh IntensiveProsun 42 Series9922525-0019922527-00K944015
42V642 SeriesVV6Luxura 42 XLUltra IntensiveProsun 42 Series9922525-0019922527-00K944015
48V648 SeriesVV6Luxura 48 XLUltra IntensiveLuxura 48 Series9922525-0029922525-00K944015
48V8-E48 SeriesVV8Luxura V8 48 E-PowerLuxura 48 Series9922525-0029922525-00K944015
48V848 SeriesVV8Luxura 48 XLUltra IntensiveLuxura 48 Series9922525-0029922525-00K944015
52X/VEGAZ52 SeriesX10/VEGAZLuxuraX10/VEGAZProsun 52 Series9922524-0019922524K944015

{8}------------------------------------------------

1.5.7 - SUMMARY OF PERFORMED TESTS

The proposed devices have been non clinically tested in accordance with:

  • . Biocompatibility and in accordance with DIN EN ISO 10993
  • . Electrical and mechanical safety in accordance with IEC 60601-1 (IEC 60335-2-27 and UL 482)
  • . EMC in accordance with IEC 60601-1-2 (CISPR 14-1 and 14-2)
  • . Spectral emissions of all sunlamp products were measured. The test procedure for measuring the spectral emission is in accordance with IEC 6033-2-27 and 21 CFR 1002, 1010 — 1050).
  • . Irradiance ratio limits of all proposed sunlamp products are in accordance with 21 CFR 1040.2(c)(1).
  • . Software verification & validation testing according to FDA's "Guidance for the Content of Premarket Submission for Software Contained in Medical Devices"
  • . The maximum timer intervals and exposure schedules have been determined according to FDA's "Policy on maximum timer interval and exposure schedule for sunlamp products."
  • . Performance Standards testing in accordance with 21 CFR 1040.20

1.5.8 — CONCLUSION

PROSUN INTERNATIONAL LLC believes that based on analysis of the technological characteristics based on non-clinical performance data and historical field experience based on the same indications for use PROSUN INTERNATIONAL LLC believes the ProSun, Lumina, Luxura, Onyx, and Jade sunlamp products are substantially equivalent to currently legally marketed predicate devices. All Special Controls for Class 2 EMDRM as defined by the FDA are fulfilled. These devices do not introduce new Indications For Use, they have the same technological characteristics and do not introduce any new issues of potential hazards, safety risks, effectiveness or usability.

§ 878.4635 Sunlamp products and ultraviolet lamps intended for use in sunlamp products.

(a)
Identification. A sunlamp product is any device designed to incorporate one or more ultraviolet (UV) lamps intended for irradiation of any part of the living human body, by UV radiation with wavelengths in air between 200 and 400 nanometers, to induce skin tanning. This definition includes tanning beds and tanning booths. A UV lamp intended for use in sunlamp products is any lamp that produces UV radiation in the wavelength interval of 200 to 400 nanometers in air.(b)
Classification. Class II (special controls). The special controls for sunlamp products and UV lamps intended for use in sunlamp products are:(1) Conduct performance testing that demonstrates the following:
(i) Device meets appropriate output performance specifications such as wavelengths, energy density, and lamp life; and
(ii) Device's safety features, such as timers to limit UV exposure and alarms, function properly.
(2) Demonstrate that device is mechanically safe to prevent user injury.
(3) Demonstrate software verification, validation, and hazard analysis.
(4) Demonstrate that device is biocompatible.
(5) Demonstrate that device is electrically safe and electromagnetically compatible in its intended use environment.
(6)
Labeling —(i)Sunlamp products. (A) The warning statement below must appear on all sunlamp products and must be placed in a black box. This statement must be permanently affixed or inscribed on the product when fully assembled for use so as to be legible and readily accessible to view by the person who will be exposed to UV radiation immediately before the use of the product. It shall be of sufficient durability to remain legible throughout the expected lifetime of the product. It shall appear on a part or panel displayed prominently under normal conditions of use so that it is readily accessible to view whether the tanning bed canopy (or tanning booth door) is open or closed when the person who will be exposed approaches the equipment and the text shall be at least 10 millimeters (height). Labeling on the device must include the following statement: Attention: This sunlamp product should not be used on persons under the age of 18 years. (B) Manufacturers shall provide validated instructions on cleaning and disinfection of sunlamp products between uses in the user instructions.
(ii)
Sunlamp products and UV lamps intended for use in sunlamp products. Manufacturers of sunlamp products and UV lamps intended for use in sunlamp products shall provide or cause to be provided in the user instructions, as well as all consumer-directed catalogs, specification sheets, descriptive brochures, and Web pages in which sunlamp products or UV lamps intended for use in sunlamp products are offered for sale, the following contraindication and warning statements:(A) “Contraindication: This product is contraindicated for use on persons under the age of 18 years.”
(B) “Contraindication: This product must not be used if skin lesions or open wounds are present.”
(C) “Warning: This product should not be used on individuals who have had skin cancer or have a family history of skin cancer.”
(D) “Warning: Persons repeatedly exposed to UV radiation should be regularly evaluated for skin cancer.”
(c)
Performance standard. Sunlamp products and UV lamps intended for use in sunlamp products are subject to the electronic product performance standard at § 1040.20 of this chapter.